HCV infection increases the expression of ACE2 receptor, leading to enhanced entry of both HCV and SARS-CoV-2 into hepatocytes and a coinfection state
Ontology highlight
ABSTRACT: this study provides the first experimental evidence for the SARS-CoV-2-HCV coinfection of liver cells, suggesting that HCV infection may be a potential risk factor for enhanced liver disease in coinfected patients. Although this outcome is supported by recent clinical findings, the specific effects of the enhanced infection SARS-CoV-2 and replication of HCV in coinfection states on liver pathology remains to be evaluated in clinical settings. In a broader view, this study emphasizes the importance of identifying coinfecting pathogens that increase the risk of SARS-CoV-2 infection and that may accelerate COVID-19-related co-morbidities.
ORGANISM(S): Homo sapiens
PROVIDER: GSE207151 | GEO | 2022/10/18
REPOSITORIES: GEO
ACCESS DATA